RBC
IBB icon

Romano Brothers & Co’s iShares Biotechnology ETF IBB Stock Holding History

Romano Brothers & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-378
Closed -$49.6K – 590
2022
Q4 		$49.6K Buy
+378
New +$48.9K 0.01% 471

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Romano Brothers & Co's IBB Position: Q1 2023 in Review

Romano Brothers & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 378 shares — an estimated $49.6K sold.

Romano Brothers & Co first reported a position in IBB in Q4 2022 and held it in 1 quarter. The position peaked at $49.6K in Q4 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • Romano Brothers & Co reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Romano Brothers & Co sold 378 iShares Biotechnology ETF shares in Q1 2023, an estimated $49.6K.
  • Romano Brothers & Co first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 1 quarter.
  • Romano Brothers & Co's iShares Biotechnology ETF position peaked at $49.6K in Q4 2022.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.